HEMADO

Description: HEMADO is a potent and selective agonist of the adenosine A3 receptor [Ki: 1.1 nM at the human A3 subtype]. Target: Others. Smiles: O[C@H]1[C@H](N2C=3C(N=C2)=C(NC)N=C(C#CCCCC)N3)O[C@H](CO)[C@H]1O. References: Klotz KN, et al. [3H]HEMADO- a novel tritiated agonist selective for the human adenosine A3 receptor. Eur J Pharmacol. 2007 Feb 5,556(1-3):14-8. Epub 2006 Oct 27.